Cook Medical is First to Win FDA Approval of Drug-Eluting Stent 11/16/2012 8:23:44 AM Cook Medical has received FDA approval for the first drug-eluting stent to treat peripheral artery disease in the U.S. The Zilver PTX Drug-Eluting Peripheral Stent is a self-expanding metal stent coated with the drug paclitaxel to help prevent recurring narrowing of the artery. Drug-eluting stents are currently approved for use in coronary arteries in heart attack patients.
The most common involvement occurs in the superficial femoral artery where most of the diseases are occlusion disease, with long occlusions where you require mostly by either stent or drug-eluting balloon. At the present movement drug eluting stent is found to be equivalent or better than that of the plain stent but newer plain stents like superior stent is equivalent to that of the drug eluting stent. .
Drug-eluting stents can continue clogged leg arteries open, preventing amputation with the leg, according to a new research presented at the Society of Interventional Radiology’s Annual …
http://www.pharmaclinicalresearch.com/2014/07/24/a-comparative-randomized-study-paclitaxel-coated-balloon-with-standard-treatment-drug-eluting-stent-during-cardiac-angioplasty/ A comparative, randomized study – Paclitaxel coated balloon with standard treatment Drug-Eluting stent during cardiac angioplasty.
Drug-Eluting Stents - A drug-eluting stent (DES) is a coronary stent (a scaffold) placed into narrowed, diseased coronary artery. It slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombus), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the coronary artery by an Interventional cardiologist during an angioplasty procedure.